Skip to main content
Top
Published in: Inflammation 5/2015

01-10-2015

Identification of Novel Inflammatory Cytokines and Contribution of Keratinocyte-Derived Chemokine to Inflammation in Response to Vibrio vulnificus Infection in Mice

Authors: Xiao-Fei Liu, Jing Wu, Ming-Yi Wang, Ying-Jian Chen, Yuan Cao, Cheng-Jin Hu

Published in: Inflammation | Issue 5/2015

Login to get access

Abstract

Currently, only tumor necrosis factor alpha (TNF-α) and interleukin family cytokines have been found to be elicited in Vibrio vulnificus (V. vulnificus)-infected animal models and humans. However, multiple other cytokines are also involved in the immune and inflammatory responses to foreign microorganism infection. Antibody array technology, unlike traditional enzyme-linked immunosorbent assay (ELISA), is able to detect multiple cytokines at one time. Therefore, in this study, we examined the proinflammatory cytokine profile in the serum and liver homogenate samples of bacterial-infected mice using antibody array technology. We identified nine novel cytokines in response to V. vulnificus infection in mice. We found that keratinocyte-derived chemokine (KC) was the most elevated cytokine and demonstrated that KC played a very important role in the V. vulnificus infection-elicited inflammatory response in mice, as evidenced by the fact that the blocking of KC by anti-KC antibody reduced hepatic injury in vivo and that KC induced by V. vulnificus infection in AML-12 cells chemoattracted neutrophils. Our findings implicate that KC may serve as a novel diagnostic biomarker and a possible therapeutic target for V. vulnificus infection.
Literature
1.
go back to reference Richards, G.P., and A. Nunez. 2006. Specificity of a Vibrio vulnificus aminopeptidase toward kinins and other peptidyl substrates. Journal of Bacteriology 188: 2056–2062.PubMedCentralCrossRefPubMed Richards, G.P., and A. Nunez. 2006. Specificity of a Vibrio vulnificus aminopeptidase toward kinins and other peptidyl substrates. Journal of Bacteriology 188: 2056–2062.PubMedCentralCrossRefPubMed
2.
go back to reference Miyamoto, K., K. Kosakai, S. Ikebayashi, T. Tsuchiya, S. Yamamoto, and H. Tsujibo. 2009. Proteomic analysis of Vibrio vulnificus M2799 grown under iron-repleted and iron-depleted conditions. Microbial Pathogenesis 46: 171–177.CrossRefPubMed Miyamoto, K., K. Kosakai, S. Ikebayashi, T. Tsuchiya, S. Yamamoto, and H. Tsujibo. 2009. Proteomic analysis of Vibrio vulnificus M2799 grown under iron-repleted and iron-depleted conditions. Microbial Pathogenesis 46: 171–177.CrossRefPubMed
3.
go back to reference Stamm, L.V. 2010. Role of TLR4 in the host response to Vibrio vulnificus, an emerging pathogen. FEMS Immunology and Medical Microbiology 58: 336–343.PubMed Stamm, L.V. 2010. Role of TLR4 in the host response to Vibrio vulnificus, an emerging pathogen. FEMS Immunology and Medical Microbiology 58: 336–343.PubMed
4.
go back to reference Chiang, S.R., H.J. Tang, P.C. Chang, K.C. Cheng, W.C. Ko, C.H. Chen, and Y.C. Chuang. 2007. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection. Journal of Microbiology, Immunology and Infection 40: 123–133. Chiang, S.R., H.J. Tang, P.C. Chang, K.C. Cheng, W.C. Ko, C.H. Chen, and Y.C. Chuang. 2007. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection. Journal of Microbiology, Immunology and Infection 40: 123–133.
5.
go back to reference Shin, S.H., D.H. Shin, P.Y. Ryu, S.S. Chung, and J.H. Rhee. 2002. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients’ sera. FEMS Immunology and Medical Microbiology 33: 133–138.CrossRefPubMed Shin, S.H., D.H. Shin, P.Y. Ryu, S.S. Chung, and J.H. Rhee. 2002. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients’ sera. FEMS Immunology and Medical Microbiology 33: 133–138.CrossRefPubMed
6.
go back to reference Powell, J.L., K.A. Strauss, C. Wiley, M. Zhan, and J.G. Morris Jr. 2003. Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress. Infection and Immunity 71: 4212–4216.PubMedCentralCrossRefPubMed Powell, J.L., K.A. Strauss, C. Wiley, M. Zhan, and J.G. Morris Jr. 2003. Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress. Infection and Immunity 71: 4212–4216.PubMedCentralCrossRefPubMed
7.
go back to reference Chuang, C.C., Y.C. Chuang, W.T. Chang, C.C. Chen, L.I. Hor, A.M. Huang, P.C. Choi, C.Y. Wang, P.C. Tseng, and C.F. Lin. 2010. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection. BMC Immunology 11: 50.PubMedCentralCrossRefPubMed Chuang, C.C., Y.C. Chuang, W.T. Chang, C.C. Chen, L.I. Hor, A.M. Huang, P.C. Choi, C.Y. Wang, P.C. Tseng, and C.F. Lin. 2010. Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection. BMC Immunology 11: 50.PubMedCentralCrossRefPubMed
8.
go back to reference Lee, N.Y., H.Y. Lee, K.H. Lee, S.H. Han, and S.J. Park. 2011. Vibrio vulnificus IlpA induces MAPK-mediated cytokine production via TLR1/2 activation in THP-1 cells, a human monocytic cell line. Molecular Immunology 49: 143–154.CrossRefPubMed Lee, N.Y., H.Y. Lee, K.H. Lee, S.H. Han, and S.J. Park. 2011. Vibrio vulnificus IlpA induces MAPK-mediated cytokine production via TLR1/2 activation in THP-1 cells, a human monocytic cell line. Molecular Immunology 49: 143–154.CrossRefPubMed
9.
go back to reference Pan, C.Y., K.C. Peng, C.H. Lin, and J.Y. Chen. 2011. Transgenic expression of tilapia hepcidin 1–5 and shrimp chelonianin in zebrafish and their resistance to bacterial pathogens. Fish & Shellfish Immunology 31: 275–285.CrossRef Pan, C.Y., K.C. Peng, C.H. Lin, and J.Y. Chen. 2011. Transgenic expression of tilapia hepcidin 1–5 and shrimp chelonianin in zebrafish and their resistance to bacterial pathogens. Fish & Shellfish Immunology 31: 275–285.CrossRef
10.
go back to reference Hsieh, J.C., C.Y. Pan, and J.Y. Chen. 2010. Tilapia hepcidin (TH)2-3 as a transgene in transgenic fish enhances resistance to Vibrio vulnificus infection and causes variations in immune-related genes after infection by different bacterial species. Fish & Shellfish Immunology 29: 430–439.CrossRef Hsieh, J.C., C.Y. Pan, and J.Y. Chen. 2010. Tilapia hepcidin (TH)2-3 as a transgene in transgenic fish enhances resistance to Vibrio vulnificus infection and causes variations in immune-related genes after infection by different bacterial species. Fish & Shellfish Immunology 29: 430–439.CrossRef
11.
go back to reference Schauer, I.G., S.J. Ressler, and D.R. Rowley. 2009. Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate 69: 373–384.PubMedCentralCrossRefPubMed Schauer, I.G., S.J. Ressler, and D.R. Rowley. 2009. Keratinocyte-derived chemokine induces prostate epithelial hyperplasia and reactive stroma in a novel transgenic mouse model. Prostate 69: 373–384.PubMedCentralCrossRefPubMed
12.
go back to reference Dale, D.C., W.C. Liles, W.R. Summer, and S. Nelson. 1995. Review: granulocyte colony-stimulating factor–role and relationships in infectious diseases. Journal of Infectious Diseases 172: 1061–1075.CrossRefPubMed Dale, D.C., W.C. Liles, W.R. Summer, and S. Nelson. 1995. Review: granulocyte colony-stimulating factor–role and relationships in infectious diseases. Journal of Infectious Diseases 172: 1061–1075.CrossRefPubMed
13.
go back to reference Deshmane, S.L., S. Kremlev, S. Amini, and B.E. Sawaya. 2009. Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon and Cytokine Research 29: 313–326.PubMedCentralCrossRefPubMed Deshmane, S.L., S. Kremlev, S. Amini, and B.E. Sawaya. 2009. Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon and Cytokine Research 29: 313–326.PubMedCentralCrossRefPubMed
14.
go back to reference Koga, S., M.B. Auerbach, T.M. Engeman, A.C. Novick, H. Toma, and R.L. Fairchild. 1999. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. Journal of Immunology 163: 4878–4885. Koga, S., M.B. Auerbach, T.M. Engeman, A.C. Novick, H. Toma, and R.L. Fairchild. 1999. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. Journal of Immunology 163: 4878–4885.
15.
go back to reference Chan, C.C., D. Shen, J.J. Hackett, R.R. Buggage, and N. Tuaillon. 2003. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology 110: 421–426.CrossRefPubMed Chan, C.C., D. Shen, J.J. Hackett, R.R. Buggage, and N. Tuaillon. 2003. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology 110: 421–426.CrossRefPubMed
16.
go back to reference Huang, H.Y., Y. Wen, J.C. Irwin, J.S. Kruessel, Y.K. Soong, and M.L. Polan. 1998. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. The Journal of Clinical Endocrinology and Metabolism 83: 1721–1729.PubMed Huang, H.Y., Y. Wen, J.C. Irwin, J.S. Kruessel, Y.K. Soong, and M.L. Polan. 1998. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. The Journal of Clinical Endocrinology and Metabolism 83: 1721–1729.PubMed
17.
go back to reference Mohamadzadeh, M., A.N. Poltorak, P.R. Bergstressor, B. Beutler, and A. Takashima. 1996. Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family. Journal of Immunology 156: 3102–3106. Mohamadzadeh, M., A.N. Poltorak, P.R. Bergstressor, B. Beutler, and A. Takashima. 1996. Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family. Journal of Immunology 156: 3102–3106.
18.
go back to reference Wu, J.C., G. Merlino, and N. Fausto. 1994. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proceedings of the National Academy of Sciences of the United States of America 91: 674–678.PubMedCentralCrossRefPubMed Wu, J.C., G. Merlino, and N. Fausto. 1994. Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proceedings of the National Academy of Sciences of the United States of America 91: 674–678.PubMedCentralCrossRefPubMed
19.
go back to reference Kim, Y.R., S.Y. Kim, C.M. Kim, S.E. Lee, and J.H. Rhee. 2005. Essential role of an adenylate cyclase in regulating Vibrio vulnificus virulence. FEMS Microbiology Letters 243: 497–503. Kim, Y.R., S.Y. Kim, C.M. Kim, S.E. Lee, and J.H. Rhee. 2005. Essential role of an adenylate cyclase in regulating Vibrio vulnificus virulence. FEMS Microbiology Letters 243: 497–503.
20.
go back to reference Li, P., G.E. Garcia, Y. Xia, W. Wu, C. Gersch, P.W. Park, L. Truong, C.B. Wilson, R. Johnson, and L. Feng. 2005. Blocking of monocyte chemoattractant protein-1 during tubulointerstitial nephritis resulted in delayed neutrophil clearance. American Journal of Pathology 167: 637–649.PubMedCentralCrossRefPubMed Li, P., G.E. Garcia, Y. Xia, W. Wu, C. Gersch, P.W. Park, L. Truong, C.B. Wilson, R. Johnson, and L. Feng. 2005. Blocking of monocyte chemoattractant protein-1 during tubulointerstitial nephritis resulted in delayed neutrophil clearance. American Journal of Pathology 167: 637–649.PubMedCentralCrossRefPubMed
21.
go back to reference Hermesh, T., T.M. Moran, D. Jain, and C.B. Lopez. 2012. Granulocyte colony-stimulating factor protects mice during respiratory virus infections. PloS One 7: e37334.PubMedCentralCrossRefPubMed Hermesh, T., T.M. Moran, D. Jain, and C.B. Lopez. 2012. Granulocyte colony-stimulating factor protects mice during respiratory virus infections. PloS One 7: e37334.PubMedCentralCrossRefPubMed
22.
go back to reference Ye, P., F.H. Rodriguez, S. Kanaly, K.L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. Journal of Experimental Medicine 194: 519–527.PubMedCentralCrossRefPubMed Ye, P., F.H. Rodriguez, S. Kanaly, K.L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. Journal of Experimental Medicine 194: 519–527.PubMedCentralCrossRefPubMed
23.
go back to reference Tekstra, J., H. Beekhuizen, J.S. Van De Gevel, I.J. Van Benten, C.W. Tuk, and R.H. Beelen. 1999. Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis. Clinical and Experimental Immunology 117: 489–495.PubMedCentralCrossRefPubMed Tekstra, J., H. Beekhuizen, J.S. Van De Gevel, I.J. Van Benten, C.W. Tuk, and R.H. Beelen. 1999. Infection of human endothelial cells with Staphylococcus aureus induces the production of monocyte chemotactic protein-1 (MCP-1) and monocyte chemotaxis. Clinical and Experimental Immunology 117: 489–495.PubMedCentralCrossRefPubMed
24.
go back to reference Kim, J.K., C.Y. Chon, J.H. Kim, Y.J. Kim, J.H. Cho, S.M. Bang, S.H. Ahn, K.H. Han, and Y.M. Moon. 2007. Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis. Journal of Interferon and Cytokine Research 27: 227–230.CrossRefPubMed Kim, J.K., C.Y. Chon, J.H. Kim, Y.J. Kim, J.H. Cho, S.M. Bang, S.H. Ahn, K.H. Han, and Y.M. Moon. 2007. Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis. Journal of Interferon and Cytokine Research 27: 227–230.CrossRefPubMed
25.
go back to reference Ichiyama, T., M. Kajimoto, N. Suenaga, S. Maeba, T. Matsubara, and S. Furukawa. 2006. Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. Journal of Neuroimmunology 172: 182–186.CrossRefPubMed Ichiyama, T., M. Kajimoto, N. Suenaga, S. Maeba, T. Matsubara, and S. Furukawa. 2006. Serum levels of matrix metalloproteinase-9 and its tissue inhibitor (TIMP-1) in acute disseminated encephalomyelitis. Journal of Neuroimmunology 172: 182–186.CrossRefPubMed
26.
go back to reference Watanabe, K., S. Kinoshita, and H. Nakagawa. 1989. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell). Biochemical and Biophysical Research Communications 161: 1093–1099.CrossRefPubMed Watanabe, K., S. Kinoshita, and H. Nakagawa. 1989. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelioid cell line of normal rat kidney (NRK-52E cell). Biochemical and Biophysical Research Communications 161: 1093–1099.CrossRefPubMed
27.
go back to reference Watanabe, K., F. Koizumi, Y. Kurashige, S. Tsurufuji, and H. Nakagawa. 1991. Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoattractant in vivo. Experimental and Molecular Pathology 55: 30–37.CrossRefPubMed Watanabe, K., F. Koizumi, Y. Kurashige, S. Tsurufuji, and H. Nakagawa. 1991. Rat CINC, a member of the interleukin-8 family, is a neutrophil-specific chemoattractant in vivo. Experimental and Molecular Pathology 55: 30–37.CrossRefPubMed
28.
go back to reference Ueland, J.M., J. Gwira, Z.X. Liu, and L.G. Cantley. 2004. The chemokine KC regulates HGF-stimulated epithelial cell morphogenesis. American Journal of Physiology. Renal Physiology 286: F581–589.CrossRefPubMed Ueland, J.M., J. Gwira, Z.X. Liu, and L.G. Cantley. 2004. The chemokine KC regulates HGF-stimulated epithelial cell morphogenesis. American Journal of Physiology. Renal Physiology 286: F581–589.CrossRefPubMed
29.
go back to reference Call, D.R., J.A. Nemzek, S.J. Ebong, G.R. Bolgos, D.E. Newcomb, G.K. Wollenberg, and D.G. Remick. 2001. Differential local and systemic regulation of the murine chemokines KC and MIP2. Shock 15: 278–284.CrossRefPubMed Call, D.R., J.A. Nemzek, S.J. Ebong, G.R. Bolgos, D.E. Newcomb, G.K. Wollenberg, and D.G. Remick. 2001. Differential local and systemic regulation of the murine chemokines KC and MIP2. Shock 15: 278–284.CrossRefPubMed
30.
go back to reference Manjavachi, M.N., R. Costa, N.L. Quintao, and J.B. Calixto. 2014. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice. Neuropharmacology 79: 17–27.CrossRefPubMed Manjavachi, M.N., R. Costa, N.L. Quintao, and J.B. Calixto. 2014. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice. Neuropharmacology 79: 17–27.CrossRefPubMed
31.
go back to reference Frink, M., Y.C. Hsieh, C.H. Hsieh, H.C. Pape, M.A. Choudhry, M.G. Schwacha, and I.H. Chaudry. 2007. Keratinocyte-derived chemokine plays a critical role in the induction of systemic inflammation and tissue damage after trauma-hemorrhage. Shock 28: 576–581.PubMed Frink, M., Y.C. Hsieh, C.H. Hsieh, H.C. Pape, M.A. Choudhry, M.G. Schwacha, and I.H. Chaudry. 2007. Keratinocyte-derived chemokine plays a critical role in the induction of systemic inflammation and tissue damage after trauma-hemorrhage. Shock 28: 576–581.PubMed
32.
go back to reference Molls, R.R., V. Savransky, M. Liu, S. Bevans, T. Mehta, R.M. Tuder, L.S. King, and H. Rabb. 2006. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. American Journal of Physiology. Renal Physiology 290: F1187–1193.CrossRefPubMed Molls, R.R., V. Savransky, M. Liu, S. Bevans, T. Mehta, R.M. Tuder, L.S. King, and H. Rabb. 2006. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. American Journal of Physiology. Renal Physiology 290: F1187–1193.CrossRefPubMed
33.
go back to reference Neels, J.G., L. Badeanlou, K.D. Hester, and F. Samad. 2009. Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. Journal of Biological Chemistry 284: 20692–20698.PubMedCentralCrossRefPubMed Neels, J.G., L. Badeanlou, K.D. Hester, and F. Samad. 2009. Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis. Journal of Biological Chemistry 284: 20692–20698.PubMedCentralCrossRefPubMed
Metadata
Title
Identification of Novel Inflammatory Cytokines and Contribution of Keratinocyte-Derived Chemokine to Inflammation in Response to Vibrio vulnificus Infection in Mice
Authors
Xiao-Fei Liu
Jing Wu
Ming-Yi Wang
Ying-Jian Chen
Yuan Cao
Cheng-Jin Hu
Publication date
01-10-2015
Publisher
Springer US
Published in
Inflammation / Issue 5/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-015-0166-5

Other articles of this Issue 5/2015

Inflammation 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.